Complement-fixing and lymphocytotoxic antibodies in serum of pregnant women at delivery II. Clinical observations I.
Sera from 2,008 pregnant women were examined for the presence of complement-fixing platelet antibodies (CFPAb) and lymphocytotoxic antibodies (LCTAb). Women with antibodies in their serum were compared with women without antibodies. No clinical significance of CFPAb or LCTAb was found as regards pre-eclampsia, arterial hypertension, albuminuria, oedema, glucosuria, premature delivery, spontaneous onset of labor and abortion.
D000022:Abortion, Spontaneous / Q000276:immunology; D000419:Albuminuria / Q000276:immunology; D001792:Blood Platelets / Q000276:immunology; D003168:Complement Fixation Tests; D003165:Complement System Proteins; D003601:Cytotoxicity Tests, Immunologic; D004487:Edema / Q000276:immunology; D005260:Female; D006029:Glycosuria; D006801:Humans; D006973:Hypertension / Q000276:immunology; D007518:Isoantibodies / Q000032:analysis*; D008214:Lymphocytes / Q000276:immunology; D008233:Lymphotoxin-alpha / Q000032:analysis; D007752:Obstetric Labor, Premature / Q000276:immunology; D011225:Pre-Eclampsia / Q000276:immunology; D011247:Pregnancy
D007518:Isoantibodies; D008233:Lymphotoxin-alpha; D003165:Complement System Proteins